Literature DB >> 31172973

The implication of adipocyte ATP-binding cassette A1 and G1 transporters in metabolic complications of obesity.

B Choromanska1, P Mysliwiec2, H R Hady2, J Dadan2, H Mysliwiec3, T Bonda4, A Chabowski5, A Miklosz5.   

Abstract

Obesity is characterised by imbalance in lipid metabolism manifested by high concentrations of circulating triacylglycerols and total cholesterol as well as low high-density lipoprotein (HDL) levels. Abnormalities related to these lipids lead to metabolic complications such as type 2 diabetes, arterial hypertension and cardiovascular disease. Despite extensive research, it is still unclear why a subset of obese subjects develop metabolic syndrome, while others do not. The aim of our work was to assess total and plasma membrane expressions of cholesterol transport proteins: adipocyte ATP-binding cassette A1 (ABCA1), adipocyte ATP-binding cassette G1 (ABCG1), class B scavenger receptor (SR-BI) in visceral and subcutaneous adipose tissue of obese subjects with and without metabolic syndrome. To keep our preliminary study group uniform, we focused on women, who constitute the majority of bariatric patients. The study was performed on 34 patients: 24 morbidly obese women subjected to bariatric surgery, half of whom had metabolic syndrome; and 10 lean subjects undergoing elective laparoscopic cholecystectomy. Total and plasma membrane expressions of cholesterol transport proteins (SR-BI, ABCA1 and ABCG1) were assessed in samples of both visceral and subcutaneous adipose and analysed in relation to other clinical and laboratory parameters. We demonstrated lower plasma membrane expressions of ABCG1 in visceral adipose tissue of obese patients with metabolic syndrome as compared to lean ones. In addition, total ABCG1 expressions in both types of adipose tissue were lower in morbidly obese patients with metabolic syndrome compared to those without metabolic syndrome. Plasma membrane ABCA1 expressions in visceral adipose tissue were lower in the group of morbidly obese patients without metabolic syndrome, compared to lean patients. We did not find any significant differences in SR-BI expressions. Because of ABCG1 is responsible for cholesterol efflux to HDL, reduced plasma membrane expression of ABCG1 in VAT of morbidly obese women with metabolic syndrome may leads to a significantly decreased concentration of HDL in serum. This may be also confirmed by high positive correlation between both parameters.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31172973     DOI: 10.26402/jpp.2019.1.14

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  8 in total

Review 1.  "Big Data" Approaches for Prevention of the Metabolic Syndrome.

Authors:  Xinping Jiang; Zhang Yang; Shuai Wang; Shuanglin Deng
Journal:  Front Genet       Date:  2022-04-27       Impact factor: 4.772

2.  Effects of SNVs in ABCA1, ABCG1, ABCG5, ABCG8, and SCARB1 Genes on Plasma Lipids, Lipoproteins, and Adiposity Markers in a Brazilian Population.

Authors:  Vanessa Helena Souza Zago; Daniel Zanetti Scherrer; Eliane Soler Parra; Isabela Calanca Vieira; Fernando Augusto Lima Marson; Eliana Cotta de Faria
Journal:  Biochem Genet       Date:  2021-09-09       Impact factor: 1.890

3.  LncRNA TUG1 regulates ApoM to promote atherosclerosis progression through miR-92a/FXR1 axis.

Authors:  Liu Yang; Tie Li
Journal:  J Cell Mol Med       Date:  2020-06-28       Impact factor: 5.310

4.  Artesunate attenuates foam cell formation by enhancing cholesterol efflux.

Authors:  Yan Qian; Li Xia; Lai Wei; Weiwei Jiang
Journal:  Ann Transl Med       Date:  2021-09

5.  ABCA1 and ABCG1 DNA methylation in epicardial adipose tissue of patients with coronary artery disease.

Authors:  Valentina V Miroshnikova; Alexandra A Panteleeva; Irina A Pobozheva; Natalia D Razgildina; Ekaterina A Polyakova; Anton V Markov; Olga D Belyaeva; Olga A Berkovich; Elena I Baranova; Maria S Nazarenko; Valery P Puzyrev; Sofya N Pchelina
Journal:  BMC Cardiovasc Disord       Date:  2021-11-27       Impact factor: 2.298

6.  Histone deacetylase 9 promoter hypomethylation associated with adipocyte dysfunction is a statin-related metabolic effect.

Authors:  Amna Khamis; Raphael Boutry; Mickaël Canouil; Sumi Mathew; Stephane Lobbens; Hutokshi Crouch; Toby Andrew; Amar Abderrahmani; Filippo Tamanini; Philippe Froguel
Journal:  Clin Epigenetics       Date:  2020-05-14       Impact factor: 6.551

7.  A Longitudinal Study of the Antioxidant Barrier and Oxidative Stress in Morbidly Obese Patients after Bariatric Surgery. Does the Metabolic Syndrome Affect the Redox Homeostasis of Obese People?

Authors:  Barbara Choromańska; Piotr Myśliwiec; Magdalena Łuba; Piotr Wojskowicz; Jacek Dadan; Hanna Myśliwiec; Katarzyna Choromańska; Anna Zalewska; Mateusz Maciejczyk
Journal:  J Clin Med       Date:  2020-04-01       Impact factor: 4.241

8.  Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimer's Disease.

Authors:  Reagon Karki; Sumit Madan; Yojana Gadiya; Daniel Domingo-Fernández; Alpha Tom Kodamullil; Martin Hofmann-Apitius
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.